Sven Dethlefs - 03 Mar 2023 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)

Role: EVP, North America Commercial
Signature: /s/ Dov Bergwerk as attorney-in-fact for Sven Dethlefs
Issuer symbol: TEVA
Transactions as of: 03 Mar 2023
Net transactions value: $0
Form type: 4
Filing time: 07 Mar 2023, 15:04:11 UTC
Previous filing: 02 Mar 2023
Next filing: 08 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TEVA	Ordinary Shares	Options Exercise		+13,931	+8.4%		179,312	04 Mar 2023	Direct	F1, F2
transaction	TEVA	Ordinary Shares	Options Exercise		+38,538	+21%		217,850	04 Mar 2023	Direct	F1, F2
transaction	TEVA	Ordinary Shares	Options Exercise		+24,952	+11%		242,802	05 Mar 2023	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TEVA	Restricted Share Units	Award	$0	+99,601		$0.000000	99,601	03 Mar 2023	Ordinary Shares	99,601		Direct	F1, F2, F3
transaction	TEVA	Restricted Share Units	Options Exercise	$0	-13,931	-100%	$0.000000^*	0	04 Mar 2023	Ordinary Shares	13,931		Direct	F1, F2, F4
transaction	TEVA	Restricted Share Units	Options Exercise	$0	-38,538	-25%	$0.000000	115,617	04 Mar 2023	Ordinary Shares	38,538		Direct	F1, F2, F5
transaction	TEVA	Restricted Share Units	Options Exercise	$0	-24,952	-33%	$0.000000	49,905	05 Mar 2023	Ordinary Shares	24,952		Direct	F1, F2, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
F2	Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
F3	Restricted share units were granted on March 3, 2023, with 24,900 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 24,901 vesting on March 3, 2027.
F4	Restricted share units were granted on March 4, 2019, with 13,930 vested on each of March 4, 2021 and March 4, 2022, and 13,931 vested on March 4, 2023.
F5	Restricted share units were granted on March 4, 2022, with 33,538 vested on March 4, 2023, 33,538 vesting on each of March 4, 2024 and March 4, 2025, and 38,541 vesting on March 4, 2026.
F6	Restricted share units were granted on March 5, 2021, with 24,952 vested on each of March 5, 2022, March 5, 2023 and March 5, 2024, and 24,953 vesting on March 5, 2025.